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The hypothesis of the possible evolutionary role of tumors
suggests that hereditary tumors may supply evolving multicellu-
lar organisms with extra cell masses for the expression of newly
evolving genes (Kozlov, 2014). After expression of novel genes in
tumor cells, tumors may differentiate in new directions and give
rise to new cell types, tissues and organs.
In the presentation, the bulk of data supporting the positive
evolutionary role of tumors will be reviewed, obtained both in
the lab of the author and from the literature sources.
The following issues will be addressed: the widespread occur-
rence of tumors in multicellular organisms; features of tumors
that could be used in evolution; the relationship of tumors to
evo-devo; examples of recapitulation of some tumor features in
recently evolved organs; the types of tumors that might play the
role in evolution; examples of tumors that already have played
the role in evolution.
The discussion of experimental confirmation of nontrivial pre-
dictions of the hypothesis will include the analysis of evolution-
ary novelty of tumor-specifically expressed EST sequences;
ELFNI – AS1, a human gene with possible microRNA function
expressed predominantly in tumors and originated in primates;
PBOV1, a human gene of the recent de novo origin with predicted
highly tumor-specific expression profile; and the evolutionary
novelty of human cancer/testis antigen genes; the data obtained
on transgenic fish tumors regression model; and other data.
It can be concluded that expression of protogenes, evolution-
arily young and/or novel genes in tumors might be a new
biological phenomenon, a phenomenon of carcino-evo-devo
genes, predicted by the hypothesis of evolution by tumor
neofunctionalization.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.050
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Integrated genomic analyses of breast cancer, relevance for better
prognosis and treatment evaluation
V. Kristensen. University of Oslo, Oslo, Norway
Combined analyses of molecular data, such as DNA copy-
number alteration, mRNA and protein expression, point to biolog-
ical functions and molecular pathways being deregulated in mul-
tiple cancers. Genomic, metabolomic and clinical data from a
variety of solid cancers and model systems are emerging and
can be used to identify novel patient subgroups for tailored ther-
apy and monitoring. The first solid tumor to be profiled by expres-
sion arrays was carcinoma of the breast. The most reproducible
classification by mRNA expression is based on the biological enti-
ties referred to as the intrinsic subtypes; Luminal A, Luminal B,
Basal-like, HER2 enriched, and the Normal-like groups. In the past
decade a number of molecular studies to classify breast cancer
have added one or two additional molecular levels, most fre-
quently DNA copy number, and gene sequencing. However, few
of the studies have integrated more than two levels of informa-
tion from the same patients. We have in our lab collected several
layers of high throughput molecular data, TP53 mutation status
and high throughput paired end sequencing on a dataset of 110
patients. This dataset was clustered according to each molecular
level studied using an unbiased, unsupervised clustering, and
survival KM plots for each patient subgroup was created. While
some samples always cluster together at any molecular level,
others cluster in different groups according to each particular
molecular endpoint. Therefore, we used an integrated approach
to understand breast cancer heterogeneity by modeling mRNA,
copy number alterations, microRNAs, and methylation in a path-
way context utilizing the pathway recognition algorithm using
data integration on genomic models (PARADIGM). We show that
massive interleukin signaling profiles are observed in invasive
cancers and are absent or weakly expressed in healthy tissue
but already prominent in ductal carcinoma in situ, together with
ECM and cell-cell adhesion regulating pathways. A good correla-
tion was observed between methylation and mRNA expression
based classification (p = 2.29  106). Using PARADIGM based on
mRNA and miRNA expression, CNAs, and methylation five new
clusters with survival differences were revealed. Given the
increasing importance of immune constitution for the success
of chemotherapy and targeted treatment, this additional infor-
mation may prove useful in the clinic in the future.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.051
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Background: The aim of this work was to assess the potential
of the optical methods for studying erythrocytes (Er) and blood
serum (BS) of patients with colorectal cancer (CC).
Methods: A total of 26 persons (52 + 8 years old) with CC (histo-
logically – adenocarcinoma) in the T1–2 stage (the 1st group con-
sisting of 10 patients) and in the terminal stage T3–4 (the 2nd
group involving 16 patients) were examined. The metastases (in
the liver area) were detected in 6 patients; the remaining patients
had no metastases. The degree of lymph node involvement in
most patients was not determined, the ten corresponding N1.
The control group consisted of 16 healthy people (50 + 6 years
old). Electric and viscoelastic Er parameters were investigated
by dielectrophoresis, their membrane structure – by TLC and
gas chromatography. The optical properties of BS were studied
by the methods of ellipsometry. The reaction of the monoclonal
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antibody CD 24 with BS antigens of CC patients was studied by
spectroscopic ellipsometry close to the conditions of surface plas-
mon resonance (SPR) (ProteOn XPR36 (BioRad).
Results: We observed significant differences in Er parameters,
associated with the CC stage. Given in the 2nd group (T3–4) sum-
marized rigidity, viscosity, electrical conductivity, the relative
polarizability, indexes of aggregation and destruction were signif-
icantly higher than those in the 1st (T1–2) and in the control
group (p < 0.001–0.05). At the same time the patients of the 2nd
group had marked disturbances of Er deformability, leading to
the development of microcirculatory disorders and tissue hypoxia
with the expressed deficit of intracellular macroergs. We
observed high levels of cholesterol fraction, oleic, stearic acids,
high index of cholesterol/phospholipids (PHL) and low levels of
total lipids, easily oxidable PHL, arachidonic acid, omega-3 index
in Er membranes in the 2nd group in comparison with those in
the 1st group of patients (p < 0.0001–0.03). Scanning ellipsometry
showed marked heterogeneity in thickness and composition,
the abundance of discontinuities in thin films of BS of patients
in the 2nd group compared to the 1st one (p < 0.001). Increasing
the refractive index in combination with the reduction in film
thickness as CC stage was weighting has been observed
(p < 0.01–0,n.05). The concentration of the antigens to the CD24
in the BS of patients (obtained by SPR) in the terminal stages of
CC was higher than that in the T1–2 (p < 0.001). We revealed cor-
relations between Er parameters, BS ellipsometry characteristics
and biochemical parameters, which reflected the interaction
between these components depending on the CC stage.
Conclusion: Identified microcirculatory disturbances probably
aggravate the course of CC and, therefore, require additional ther-
apeutic effects. Differences in Er and BS parameters associated
with the stage of CC, give hope for the development of new diag-
nostic methods at the early stages of the disease.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.052
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Growing tumor and its microenvironment are capable to pro-
duce a number of cytokines that alter the nature of the antitumor
surveillance by host immune system.
Objective: Comparative evaluation of cytokine-producing
function of the invasive ductal carcinoma and fibroadenoma of
the breast in vitro.
Materials and methods: Similar biopsies (V = 8 mm3) of the
breast tumors were obtained using a special device, cultivated
in DMEM F-12 at 37 C for 72 h. Concentrations of the following
cytokines: IL-1b, IL-1Ra, TNFa, IL-2, IL-6, IL-8, IL-10, IL-17, IL-18,
VEGF and IFNc in the supernatant of the tumor were measured
with enzyme-linked immunosorbent assay (ELISA).
Results: The investigation of cytokines level in the supernatant
of malignant and benign breast tumors revealed significant differ-
ences only in concentrations of IL-10, IL-17, IL-18 and IFNc which
had a contrary tendency. For example, the concentration of IL-10
was lower at invasive ductal carcinoma in comparison with
fibroadenomas. The concentrations of IL-17, IL-18 and IFNc at
invasive ductal carcinoma were significantly higher than those
of breast fibroadenomas. IL-17 and IL-18 are known to be pro-
oncogenic cytokines, and the higher the level, the higher the
severity of tumor progression. Reduction in the IL-10 concentra-
tion might be explained by the already formed neoplasm, which
depends on angiogenesis. In this case, IL-10 no longer exerts
antiangiogenic action, which contributes to tumor progression.
Reduction in the IL-10 concentration, which inhibits the produc-
tion of IFNc leads to an increase in the IFNc level. In early stages
of tumor development, IFNc provides an antitumor effect and at
the same time facilitates the selection of a moremalignant clones
but its pro-tumoral action predominates at advanced stages of
tumorigenesis. Moreover, higher concentration of IFNc is sup-
posed to be associated with biological effects of IL-18, which is
its immediate inductor. In addition, malignant tumor cells are
capable to produce their own IL-18, which stimulates tumor
progression and facilitates the migration of endothelial cells
involved in angiogenesis, which leads to intensified invasion
and metastasis.
Conclusion: Cytokine production in supernatants of invasive
ductal carcinoma compared with fibroadenoma of the breast is
characterized by increase in IL-17, IL-18 and IFNc concentrations
and decrease in IL-10 concentration. Findings suggest the ability
of malignant tumor and its microenvironment to secrete the
pro-oncogenic cytokines. Fibroadenoma is also able to produce
cytokines due to fibroblasts, fibrocytes and some leukocytes in
its content.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.053
P53
Long-term monitoring of the digestive cancer in Novosibirsk
S. Kurilovicha,b,*, V. Reshetnikova, T. Nikitenkoa. a Federal State
Budgetary Scientific Institution Institute of Internal and Preventive
Medicine, Novosibirsk, Russian Federation, bNovosibirsk State
Medical University, Russian Federation
⇑
Corresponding author.
This study used data from population-based cancer registries
and total mortality over the past quarter of a century in NIITPM,
Novosibirsk. The follow-up period was from 1985 to 2014. Both
registers operated in the two regions, the most typical for the city.
The results can be extrapolated to the entire population of
Novosibirsk. For long-term analysis we used data from two regis-
ters concerning gastric cancer, colorectal cancer and liver cancer.
Morbidity and mortality from stomach cancer over the past
25 years have declined, however, the proportion of GC 3–4
(end-stage) remains constant with a tendency to increase. In
general, the incidence of colorectal cancer in the Novosibirsk
30 EJC SUPPLEMENTS 13 (2015) 1–75
